XML 13 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Shares and Stockholders' Equity
9 Months Ended
Sep. 30, 2019
Shares and Stockholders' Equity [Abstract]  
Shares and Stockholders' Equity

13. Shares and Stockholders’ Equity

Common Shares

The changes in our common stock (number of shares) were as follows:

For the Three

For the Nine

Months Ended

Months Ended

September 30,

September 30,

2019

2018

2019

2018

Common Stock

Balance as of beginning-of-period

200,775,731

217,294,051

205,862,760

218,090,114

Stock issued for exercise of warrants

36,610

97,076

258,633

119,942

Stock compensation/issued for benefit plans

41,006

38,642

934,081

675,608

Retirement/cancellation of shares

(2,526,097

)

(2,652,963

)

(8,728,224

)

(4,108,858

)

Balance as of end-of-period

198,327,250

214,776,806

198,327,250

214,776,806

Common Stock as of End-of-Period

Basic basis

198,327,250

214,776,806

198,327,250

214,776,806

Diluted basis

200,724,744

217,390,897

200,724,744

217,390,897

Our common stock is without par value.

Average Shares

A reconciliation of the denominator (number of shares) in the calculations of basic and diluted earnings (loss) per common share was as follows:

For the Three

For the Nine

Months Ended

Months Ended

September 30,

September 30,

2019

2018

2019

2018

Weighted-average shares, as used in basic calculation

199,200,811

215,901,268

201,644,591

217,413,480

Shares to cover exercise of outstanding warrants

4,033

579,882

78,353

620,580

Shares to cover non-vested stock

935,823

1,467,953

938,920

1,512,297

Average stock options outstanding during the period

1,443,508

1,700,026

1,536,738

1,807,340

Assumed acquisition of shares with assumed proceeds

from exercising outstanding warrants

(588

)

(86,040

)

(12,791

)

(86,335

)

Assumed acquisition of shares with assumed

proceeds and benefits from exercising stock

options (at average market price for the period)

(988,853

)

(1,082,651

)

(1,050,065

)

(1,090,868

)

Shares repurchasable from measured but

unrecognized stock option expense

-

(11,209

)

(289

)

(17,381

)

Average deferred compensation shares

966,444

-

-

936,355

Weighted-average shares, as used in diluted calculation (1)

201,561,178

218,469,229

203,135,457

221,095,468

(1)Due to reporting a net loss for the three months ended September 30, 2019, basic shares were used in the diluted earnings per share (“EPS”) calculation for that period as the use of diluted shares would have resulted in a lower loss per share.

In the event the average market price of LNC common stock exceeds the issue price of stock options and the options have a dilutive effect to our EPS, such options will be shown in the table above.

We have participants in our deferred compensation plans who selected LNC stock as the measure for the investment return attributable to all or a portion of their deferral amounts. For the three months ended September 30, 2019 and the nine months ended September 30, 2018, the effect of settling this obligation in LNC stock (“equity classification”) was more dilutive than the scenario of settling in cash (“liability classification”). Therefore, for our EPS calculation for these periods, we added these shares to the denominator and adjusted the numerator to present net income as if the shares had been accounted for under equity classification by removing the mark-to-market adjustment included in net income attributable to these deferred units of LNC stock. The amount of this adjustment was $3 million for the three months ended September 30, 2019 and $6 million for the nine months ended September 30, 2018.


AOCI

The following summarizes the components and changes in AOCI (in millions):

For the Nine

Months Ended

September 30,

2019

2018

Unrealized Gain (Loss) on AFS Securities

Balance as of beginning-of-year

$

557

$

3,486

Cumulative effect from adoption of new accounting standards

-

674

Unrealized holding gains (losses) arising during the period

9,849

(5,520

)

Change in foreign currency exchange rate adjustment

(80

)

(68

)

Change in DAC, VOBA, DSI, future contract benefits and other contract holder funds

(2,271

)

1,538

Income tax benefit (expense)

(1,596

)

858

Less:

Reclassification adjustment for gains (losses) included in net income (loss)

(18

)

(35

)

Associated amortization of DAC, VOBA, DSI and DFEL

(11

)

(15

)

Income tax benefit (expense)

6

11

Balance as of end-of-period

$

6,482

$

1,007

Unrealized OTTI on AFS Securities

Balance as of beginning-of-year

$

33

$

44

(Increases) attributable to:

Cumulative effect from adoption of new accounting standards

-

9

Gross OTTI recognized in OCI during the period

(16

)

-

Change in DAC, VOBA, DSI and DFEL

1

-

Income tax benefit (expense)

3

-

Decreases attributable to:

Changes in fair value, sales, maturities or other settlements of AFS securities

21

(8

)

Change in DAC, VOBA, DSI and DFEL

(2

)

(10

)

Income tax benefit (expense)

(4

)

4

Balance as of end-of-period

$

36

$

39

Unrealized Gain (Loss) on Derivative Instruments

Balance as of beginning-of-year

$

139

$

(29

)

Cumulative effect from adoption of new accounting standard

-

(6

)

Unrealized holding gains (losses) arising during the period

(152

)

98

Change in foreign currency exchange rate adjustment

80

69

Change in DAC, VOBA, DSI and DFEL

(3

)

8

Income tax benefit (expense)

15

(37

)

Less:

Reclassification adjustment for gains (losses) included in net income (loss)

34

15

Associated amortization of DAC, VOBA, DSI and DFEL

(1

)

(1

)

Income tax benefit (expense)

(7

)

(3

)

Balance as of end-of-period

$

53

$

92

Foreign Currency Translation Adjustment

Balance as of beginning-of-year

$

(23

)

$

(14

)

Foreign currency translation adjustment arising during the period

(5

)

(6

)

Balance as of end-of-period

$

(28

)

$

(20

)

Funded Status of Employee Benefit Plans

Balance as of beginning-of-year

$

(299

)

$

(257

)

Cumulative effect from adoption of new accounting standard

-

(35

)

Adjustment arising during the period

4

10

Balance as of end-of-period

$

(295

)

$

(282

)


The following summarizes the reclassifications out of AOCI (in millions) and the associated line item in the Consolidated Statements of Comprehensive Income (Loss):

For the Nine

Months Ended

September 30,

2019

2018

Unrealized Gain (Loss) on AFS Securities

Gross reclassification

$

(18

)

$

(35

)

Total realized gain (loss)

Associated amortization of DAC,

VOBA, DSI and DFEL

(11

)

(15

)

Total realized gain (loss)

Reclassification before income

Income (loss) from continuing

tax benefit (expense)

(29

)

(50

)

operations before taxes

Income tax benefit (expense)

6

11

Federal income tax expense (benefit)

Reclassification, net of income tax

$

(23

)

$

(39

)

Net income (loss)

Unrealized OTTI on AFS Securities

Gross reclassification

$

4

$

(1

)

Total realized gain (loss)

Change in DAC, VOBA, DSI and DFEL

-

-

Total realized gain (loss)

Reclassification before income

Income (loss) from continuing

tax benefit (expense)

4

(1

)

operations before taxes

Income tax benefit (expense)

(1

)

-

Federal income tax expense (benefit)

Reclassification, net of income tax

$

3

$

(1

)

Net income (loss)

Unrealized Gain (Loss) on Derivative Instruments

Gross reclassifications:

Interest rate contracts

$

2

$

3

Net investment income

Interest rate contracts

(2

)

(6

)

Interest and debt expense

Foreign currency contracts

25

18

Net investment income

Foreign currency contracts

9

-

Total realized gain (loss)

Total gross reclassifications

34

15

Associated amortization of DAC,

VOBA, DSI and DFEL

(1

)

(1

)

Commissions and other expenses

Reclassifications before income

Income (loss) from continuing

tax benefit (expense)

33

14

operations before taxes

Income tax benefit (expense)

(7

)

(3

)

Federal income tax expense (benefit)

Reclassifications, net of income tax

$

26

$

11

Net income (loss)